That was refreshing

Recently Jo and I have been consistently disappointed when we went to club parties and most meet and greets. The people didn’t match our physical criteria and weren’t a good the personality/social-economic match for us either.

But about a month ago we met a couple at a meet and greet which lives about a mile from us, both are tall and in good shape, and it seemed to be a good match. We exchanged contact information and with the expectation they would get in touch with us for a “vanilla” party at their home the following day with some of their family and friends. That didn’t happen and we gave them a pass on it. It was a little early in the relationship to know if we could be trusted to keep our hands off of people and not bring up lifestyle things in front of people they didn’t want knowing.

But nothing further came from them and so we reached out to them last week to see if they would like to have dinner with us at a local restaurant. They agreed and we had dinner with them last night. It went really well. We talked and talked about a number of things both about the lifestyle and non-lifestyle. We got along great and they invited us to another vanilla event at their home and verified we are all going to the same exclusive sex club party a couple weeks from now.

I’m really looking forward to it.

Progress in HIV research

STIs are a major concern for many people in the lifestyle and HIV is probably the most feared. After several years in the lifestyle my ex-wife and I had our last sexual contact with others at a Memorial Day weekend party in 1983. We stopped because of the concern about HIV. Once or twice a year we cautiously, with condoms, played with others who had also “taken a break” for a long time. It wasn’t until 1995 that lifestyle things sort of returned to normal. Condoms were required except for “closed communities” of select couples who also restricted themselves to playing within our “community”.

Now there is some significant hope for a HIV vaccine  and perhaps cure:

Scientists have engineered an antibody that attacks 99% of HIV strains and can prevent infection in primates.

It is built to attack three critical parts of the virus – making it harder for HIV to resist its effects.

The work is a collaboration between the US National Institutes of Health and the pharmaceutical company Sanofi.

The International Aids Society said it was an “exciting breakthrough”. Human trials will start in 2018 to see if it can prevent or treat infection.